
358: FDA's gene therapy turmoil, and an alternative model for funding research
The Readout Loud
00:00
Funding Dilemmas in Academia
This chapter delves into the implications of Harvard University's investment from a Turkish private equity firm, raising concerns about the influence of corporate funding on academic research. It emphasizes the balance researchers must maintain between securing financial support and upholding the integrity of scientific inquiry, while also discussing the potential impact on important drug developments like lenacaprevir.
Transcript
Play full episode